| Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study QD Nguyen, SM Shah, AA Khwaja, R Channa, E Hatef, DV Do, D Boyer, ... Ophthalmology 117 (11), 2146-2151, 2010 | 782 | 2010 |
| 8 Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study. CPA Nguyen QD, Shah SM, Heier JS, Do DV, Lim J, Boyer D, Abraham P, ... Ophthalmology, 2009 | 505 | 2009 |
| Epidemiology of eye-related emergency department visits R Channa, SN Zafar, JK Canner, RS Haring, EB Schneider, DS Friedman JAMA ophthalmology 134 (3), 312-319, 2016 | 318 | 2016 |
| Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36 EY Chew, TE Clemons, E Agrón, RD Sperduto, JP SanGiovanni, ... JAMA ophthalmology 132 (3), 272-277, 2014 | 260 | 2014 |
| Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment DV Do, QD Nguyen, AA Khwaja, R Channa, YJ Sepah, R Sophie, G Hafiz, ... JAMA ophthalmology 131 (2), 139-145, 2013 | 251 | 2013 |
| Non‐steroidal anti‐inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery VV Juthani, E Clearfield, RS Chuck Cochrane Database of Systematic Reviews, 2017 | 158 | 2017 |
| Treatment of diabetic macular edema with a designed ankyrin repeat protein that binds vascular endothelial growth factor: a phase I/II study PA Campochiaro, R Channa, BB Berger, JS Heier, DM Brown, U Fiedler, ... American journal of ophthalmology 155 (4), 697-704. e2, 2013 | 157 | 2013 |
| Ultra-wide-field retinal imaging in the management of non-infectious retinal vasculitis HA Leder, JP Campbell, YJ Sepah, T Gan, JP Dunn, E Hatef, B Cho, ... Journal of ophthalmic inflammation and infection 3, 1-6, 2013 | 142 | 2013 |
| Epidemiologic trends of chemical ocular burns in the United States RS Haring, ID Sheffield, R Channa, JK Canner, EB Schneider JAMA ophthalmology 134 (10), 1119-1124, 2016 | 139 | 2016 |
| Wide-field retinal imaging in the management of noninfectious posterior uveitis JP Campbell, HA Leder, YJ Sepah, T Gan, JP Dunn, E Hatef, B Cho, ... American journal of ophthalmology 154 (5), 908-911. e2, 2012 | 139 | 2012 |
| Encephalitis and myelitis associated with dengue viral infection: Clinical and neuroimaging features M Wasay, R Channa, M Jumani, G Shabbir, M Azeemuddin, A Zafar Clinical neurology and neurosurgery 110 (6), 635-640, 2008 | 129 | 2008 |
| Alterations in the retinal vasculature occur in multiple sclerosis and exhibit novel correlations with disability and visual function measures OC Murphy, O Kwakyi, M Iftikhar, S Zafar, J Lambe, N Pellegrini, ... Multiple Sclerosis Journal 26 (7), 815-828, 2020 | 101 | 2020 |
| Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes PA Campochiaro, G Hafiz, R Channa, SM Shah, QD Nguyen, H Ying, ... Ophthalmology 117 (12), 2387-2394. e5, 2010 | 90 | 2010 |
| Factors affecting visual outcomes in patients with diabetic macular edema treated with ranibizumab R Channa, R Sophie, AA Khwaja, DV Do, G Hafiz, QD Nguyen, ... Eye 28 (3), 269-278, 2014 | 86 | 2014 |
| Characterization of macular lesions in punctate inner choroidopathy with spectral domain optical coherence tomography R Channa, M Ibrahim, Y Sepah, P Turkcuoglu, JH Lee, A Khwaja, E Hatef, ... Journal of ophthalmic inflammation and infection 2, 113-120, 2012 | 84 | 2012 |
| Cost-effectiveness of autonomous point-of-care diabetic retinopathy screening for pediatric patients with diabetes RM Wolf, R Channa, MD Abramoff, HP Lehmann JAMA ophthalmology 138 (10), 1063-1069, 2020 | 74 | 2020 |
| Treatment of macular edema due to retinal vein occlusions R Channa, M Smith, PA Campochiaro Clinical Ophthalmology, 705-713, 2011 | 67 | 2011 |
| Retinal neurodegeneration as an early manifestation of diabetic eye disease and potential neuroprotective therapies S Zafar, M Sachdeva, BJ Frankfort, R Channa Current diabetes reports 19, 1-13, 2019 | 66 | 2019 |
| Pro-permeability factors in diabetic macular edema; the diabetic macular edema treated with ozurdex trial PA Campochiaro, G Hafiz, TA Mir, AW Scott, I Zimmer-Galler, SM Shah, ... American journal of ophthalmology 168, 13-23, 2016 | 66 | 2016 |
| Regression of choroidal neovascularization results in macular atrophy in anti-vascular endothelial growth factor-treated eyes R Channa, R Sophie, S Bagheri, SM Shah, J Wang, O Adeyemo, A Sodhi, ... American journal of ophthalmology 159 (1), 9-19. e2, 2015 | 66 | 2015 |
